LDS/Medical Tests/Beta-Glucuronidase, Blood

Beta-Glucuronidase, Blood

β-glucuronidase is a lysosomal hydrolytic enzyme responsible for the cleavage of the terminal β-D-glucuronic acid residue from complex carbohydrate mucopolysaccharides. The enzyme is produced by the GUSB gene, which is located on the long arm of chromosome at position 7q11.21. At least 45 different mutations have been identified that result in a deficiency of β-glucuronidase resulting in mucopolysaccharidosis VII (MPS VII) also known as Sly syndrome. Decrease function of the enzyme is also seen in GM1 gangliosidosis, Morquio syndrome B, and Galactosialidosis.

MPS VII or Sly syndrome is inherited in autosomal recessive and is characterized by the accumulation of glycosaminoglycans (GAGs) including heparin, chondroitin and dermatan sulfate in the lysosome of various tissues including the central nervous system (CNS). The most severe cases of Sly syndrome are characterized by hydrops fetalis resulting in stillbirth or death soon after birth. Milder forms the disease are manifested during early childhood as macrocephaly, coarse facial features, hepatosplenomegaly, cloudy cornea, cardiac abnormalities and skeletal dysplasia. GM1 gangliosidosis, Morquio syndrome B, and galactosialidosis are also autosomal recessive neuromuscular degenerative disorders caused by the decrease function in hydrolases enzymes including β-glucuronidase.

Decreased beta-galactosidase enzyme activity will aid in diagnosis of MPS VII or Sly syndrome, GM1 gangliosidosis, Morquio B, or galactosialidosis; however, additional testing is necessary to differentiate between these conditions. For example, in addition to decreased beta-galactosidase enzyme activity, abnormalities in urine oligosaccharides and elevated keratan sulfate in urine are indicative of GM1 gangliosidosis. In contrast, individuals with Morquio B can have increased keratan sulfate in urine but no abnormality in urine oligosaccharides.

Molecular sequence analysis of the GUSB gene will confirm the diagnosis of Sly syndrome, whereas sequence analysis of GLB1 gene allows for detection of the disease-causing mutations in affected patients with GM1 gangliosidosis and Morquio B. Enzymatic testing is not reliable to detect carriers.

  • As an aid in the diagnosis of mucopolysaccharidosis VII (Sly syndrome)
  • As an aid in diagnosis of GM1 gangliosidosis, Morquio syndrome B, and galactosialidosis

Decreased in:

  • Mucopolysaccharidosis VII
  • GM1 gangliosidosis
  • Morquio syndrome B
  • Galactosialidosis

Whole blood: 165 – 585 nmol/hour/mg of protein

Skin fibroblast: 66 – 186 nmol/hour/mg of protein

Fluorometric assay.

Whole blood (ACD or Heparin), Cultured cells from skin fibroblast.

Stability

  • Ambient: not recommended
  • Refrigerated: 24 hours
Molecular genetic testing for GUSB gene, Urinary glycosaminoglycans.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Birth Defects Orig Artic Ser. 1974;10:239-45. [PMID: 4282258]
  • Mol Genet Metab. 2008 Aug;94(4):391-6. [PMID: 18524657]
  • J Pediatr. 1973 Feb;82(2):249-57. [PMID: 4265197]
  • Clin Biochem. 2017;50:1243-1248. Sep 27. [PMID: 28962937]
  • Wraith JE, Chapter 102 – Mucopolysaccharidoses. Emery and Rimoin's Principles and Practice of Medical Genetics. Academic press 2013, Page 1-40.